Recruiting NA INTERVENTIONAL 2-arm NCT05477797

Id and Rd Maintenance Regimens After Induction of Remission in Multiple Myeloma.

Id and Rd Maintenance Regimens After Induction of Remission in Multiple Myeloma: a Prospective, Randomized, Controlled, Multicenter Clinical Study

Sponsor: RenJi Hospital

Conditions Maintenance Overall Survival Progression Free Survival

Interventions Ixazomib DX/Lenalidomide DX

Updated 5 times since 2022 Last updated: Apr 12, 2024 Started: Feb 16, 2023 Primary completion: Jan 15, 2026 Completion: Jan 15, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Maintenance and Overall Survival, this trial is actively recruiting participants. The trial is conducted by RenJi Hospital and has accumulated 5 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
May 2024 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Mar 2023 — May 2024 [monthly]

Not Yet Recruiting NA
Sep 2022 — Mar 2023 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

RenJi Hospital

Data source: RenJi Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China